Botanical Injection > 주식회사 로드제약기술

Botanical Injection
Botanical Injection
SBI-904
Malignant Ascites Treatment Market Size and Forecast
2023 Market Size: Approximately $530 million
2025 Market Size: Approximately $674 million (1 trillion KRW)
2035 Estimated Market Size: $1,533.6 million
Compound Annual Growth Rate (CAGR): Approximately 8.6%

Removab (Catumaxomab) - Comparative Products
Removab (Catumaxomab): EpCAM (epithelial cell adhesion molecule)-positive carcinoma - unique product
2009: Granted conditional marketing authorization in Europe for Fresenius Biotech – significant side effects
2017: Withdrawn from the market, official sales data not disclosed
February 2025: Lindis Biotech GmbH re-approved Korjuny (Catumaxomab) by the EMA
Manufacturing Facilities